Elekta’s newest software is gaining traction in Europe and its service business keeps growing, which could make revenue steadier as more hospitals upgrade to more precise cancer treatment tools. The big question is whether China rebounds as expected while tariffs, currency swings, approvals, and tougher competition keep pressure on profits.Read more
Elekta could get a bigger boost than many expect as newer cancer treatment systems and software spread quickly in Europe, China, and other underserved regions, shifting more of its business toward repeat service and software income. But trade barriers, currency swings, and uneven demand in key markets could squeeze profits and make growth less reliable.Read more
Key Takeaways Rising global trade barriers, reimbursement pressures, and aggressive competition are constraining margins, threatening earnings predictability, and slowing potential revenue growth across Elekta's markets. Underinvestment in R&D and operational challenges in emerging markets are eroding Elekta's technological edge and compressing both current and future profitability.Read more
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear machines and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo, a CT-Linac solution; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit, a gamma knife system; and Elekta Care, a personalized services for radiotherapy suites. In addition, the company offers brachytherapy products, including Elekta Studio, an image-guided brachytherapy solution; ImagingRing for dynamic imaging; Oncentra Brachy, a smart tool that facilitates repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Elekta Geneva, an applicator for cervical cancer patients; and Elekta Xoft Axxent electronic brachytherapy systems. Further, it provides Leksell Vantage Stereotactic System, a neurosurgery product; Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. Additionally, the company offers Elekta Care 360, which provides a range of clinical and professional services; Elekta Care Learning; Elekta Care Community, a self-help center; and Elekta Partner Community, an online self-service portal. Elekta AB (publ) was incorporated in 1972 and is headquartered in Stockholm, Sweden.
